FDA Inspection 1102672 — Kaiser Permanente Center For Reproductive Health
The FDA completed an inspection of Kaiser Permanente Center For Reproductive Health on Sep 12, 2019 in Fremont, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 12, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Fremont, CA (United States)